Immunotherapy with Checkpoint Inhibitors for Non-small Cell Lung Cancer, Colon Cancer and Esophageal Cancer

116k
Total downloads
291k
Total views and downloads

Download PDF Download EPUB

Articles

ORIGINAL RESEARCH

Published on 22 Jul 2022

Cost-Utility Analysis of Camrelizumab Plus Chemotherapy Versus Chemotherapy Alone as a First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer in China

Ting Chen
Ruixiang Xie
Qiuling Zhao
Hongfu Cai
Lin Yang

doi 10.3389/fonc.2022.746526

1,460 views
8 citations

CASE REPORT

Published on 03 Jun 2022

Upper Gastrointestinal Tract IrAEs: A Case Report About Sintilimab-Induced Acute Erosive Hemorrhagic Gastritis

Qi Ai
Wen Chen
Yonggui Li
Guoqing Li

doi 10.3389/fimmu.2022.840916

2,689 views
8 citations

ORIGINAL RESEARCH

Published on 03 Jun 2022

ASCL2 Affects the Efficacy of Immunotherapy in Colon Adenocarcinoma Based on Single-Cell RNA Sequencing Analysis

Lei Wu
Shengnan Sun
Fei Qu
Xiuxiu Liu
Meili Sun
Ying Pan
Yan Zheng
Guohai Su

doi 10.3389/fimmu.2022.829640

4,307 views
5 citations

ORIGINAL RESEARCH

Published on 28 Apr 2022

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Colon Cancer to Immunotherapy

Zheng Wang
Jingru Song
Nisma Lena Bahaji Azami
Mingyu Sun

doi 10.3389/fimmu.2022.802665

3,288 views
9 citations

ORIGINAL RESEARCH

Published on 22 Apr 2022

The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma

Xizhe Li
Ziyu Dai
Xianning Wu
Nan Zhang
Hao Zhang
Zeyu Wang
Xun Zhang
Xisong Liang
Peng Luo
4 more
Ruimin Chang

doi 10.3389/fimmu.2022.749241

9,874 views
26 citations

ORIGINAL RESEARCH

Published on 22 Apr 2022

Predicting Durable Responses to Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer Using a Multi-Feature Model

Lei Wang
Hongbing Zhang
Chaohu Pan
Jian Yi
Xiaoli Cui
Na Li
Jiaqian Wang
Zhibo Gao
Dongfang Wu
2 more
Qian Chu

doi 10.3389/fimmu.2022.829634

2,864 views
9 citations

ORIGINAL RESEARCH

Published on 14 Apr 2022

TNF-α-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 Immunotherapy

Kirsten De Ridder
Hanne Locy
Elisa Piccioni
Miren Ibarra Zuazo
Robin Maximilian Awad
Stefaan Verhulst
Mathias Van Bulck
Yannick De Vlaeminck
Quentin Lecocq
9 more
Cleo Goyvaerts

doi 10.3389/fimmu.2022.811867

5,006 views
15 citations

REVIEW

Published on 07 Apr 2022

Checkpoint Inhibitor Pneumonitis Induced by Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer: Occurrence and Mechanism

Jianqiong Yin
Yuanjun Wu
Xue Yang
Lu Gan
Jianxin Xue

doi 10.3389/fimmu.2022.830631

12,014 views
48 citations

ORIGINAL RESEARCH

Published on 07 Apr 2022

Non-Invasive Measurement Using Deep Learning Algorithm Based on Multi-Source Features Fusion to Predict PD-L1 Expression and Survival in NSCLC

Chengdi Wang
Jiechao Ma
Jun Shao
Shu Zhang
Jingwei Li
Junpeng Yan
Zhehao Zhao
Congchen Bai
Yizhou Yu
Weimin Li

doi 10.3389/fimmu.2022.828560

4,435 views
48 citations

ORIGINAL RESEARCH

Published on 05 Apr 2022

What Is Long-Term Survival and Which First-Line Immunotherapy Brings Long-Term Survival for Advanced Wild-Type Non-Small Cell Lung Cancer: A Network Meta-Analysis Based on Integrated Analysis

Xue Zhang
Qian Xu
Xuejun Yu
Miao Huang
Song Li
Lei Sheng
Xin Dai
Kai Huang
Jian Wang
Lian Liu

doi 10.3389/fimmu.2022.764643

4,624 views
7 citations

CASE REPORT

Published on 01 Apr 2022

Nivolumab Combined With Ipilimumab Treatment Induced Hypophysitis and Immune-Mediated Liver Injury in Advanced Esophageal Squamous Cell Carcinoma: A Case Report

Yi Feng
Chengyang Li
Yuan Ji
Ying Liu
Lu Gan
Yiyi Yu
Tianshu Liu

doi 10.3389/fonc.2022.801924

2,189 views
4 citations

ORIGINAL RESEARCH

Published on 31 Mar 2022

Visual Analysis of Colorectal Cancer Immunotherapy: A Bibliometric Analysis From 2012 to 2021

Long Ma
Jixiang Ma
Muzhou Teng
Yumin Li

doi 10.3389/fimmu.2022.843106

7,403 views
49 citations

Share on

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.5 impact factor
- 6.2 citescore

Impact

291kTopic views
171kArticle views
116kArticle downloads

View impact

Submit your idea

Articles

Cost-Utility Analysis of Camrelizumab Plus Chemotherapy Versus Chemotherapy Alone as a First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer in China

Upper Gastrointestinal Tract IrAEs: A Case Report About Sintilimab-Induced Acute Erosive Hemorrhagic Gastritis

ASCL2 Affects the Efficacy of Immunotherapy in Colon Adenocarcinoma Based on Single-Cell RNA Sequencing Analysis

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Colon Cancer to Immunotherapy

The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma

Predicting Durable Responses to Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer Using a Multi-Feature Model

TNF-α-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 Immunotherapy

Checkpoint Inhibitor Pneumonitis Induced by Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer: Occurrence and Mechanism

Non-Invasive Measurement Using Deep Learning Algorithm Based on Multi-Source Features Fusion to Predict PD-L1 Expression and Survival in NSCLC

What Is Long-Term Survival and Which First-Line Immunotherapy Brings Long-Term Survival for Advanced Wild-Type Non-Small Cell Lung Cancer: A Network Meta-Analysis Based on Integrated Analysis

Nivolumab Combined With Ipilimumab Treatment Induced Hypophysitis and Immune-Mediated Liver Injury in Advanced Esophageal Squamous Cell Carcinoma: A Case Report

Visual Analysis of Colorectal Cancer Immunotherapy: A Bibliometric Analysis From 2012 to 2021

Frontiers in Immunology

Participating Journals

Impact